Skip to main content
. 2017 May 12;2017:bcr2017219956. doi: 10.1136/bcr-2017-219956

Figure 1.

Figure 1

Portable chest radiographs with preinfliximab treatment on the left and diffuse ground-glass opacities as a complication after 2 weeks of receiving the third dose of the accelerated infliximab regimen in the treatment of severe ulcerative colitis on the right.